Last reviewed · How we verify
Grippol® Quadri
At a glance
| Generic name | Grippol® Quadri |
|---|---|
| Sponsor | NPO Petrovax |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Grippol® Quadri CI brief — competitive landscape report
- Grippol® Quadri updates RSS · CI watch RSS
- NPO Petrovax portfolio CI